NeuWave Breakfast Symposium
The Data Is In: NeuWave’s Ablation Confirmation Impacted Treatment in 20% of Cases & Impacts Clinical Decision Making
Shane Wells, MD
William Alago, MD, FSIR
Breakfast will be served, seating is limited.
Presented by NeuWave.
The asset you are trying to access is locked. Please enter your access key to unlock.